Brain accumulation of the EML4-ALK inhibitor ceritinib is restricted by P-glycoprotein (P-GP/ABCB1) and breast cancer resistance protein (BCRP/ABCG2).
Kort, Anita a, c; Sparidans, Rolf W. b; Wagenaar, Els a; Beijnen, Jos H. b, c, d; Schinkel, Alfred H. a, *
[Article] Pharmacological Research. 102 Supplement C:200-207, December 2015.

(Format: HTML, PDF)

(C) 2015Elsevier, Inc.